Eledon Pharmaceuticals Shares Are Trading Lower After the Company Announced an $50 Million Oversubscribed Private Placement. The Company Announced Clinical Progress With Tegoprubart in the Prevention of Transplant Rejection.
Eledon Pharmaceuticals Shares Are Trading Lower After the Company Announced an $50 Million Oversubscribed Private Placement. The Company Announced Clinical Progress With Tegoprubart in the Prevention of Transplant Rejection.
Eledon Pharmicals宣布超额认购5000万美元的私募配售后，该公司股价走低。该公司宣布了Tegoprubart在预防移植排斥反应方面的临床进展。
Eledon Pharmaceuticals Shares Are Trading Lower After the Company Announced an $50 Million Oversubscribed Private Placement. The Company Announced Clinical Progress With Tegoprubart in the Prevention of Transplant Rejection.
Eledon Pharmicals宣布超额认购5000万美元的私募配售后，该公司股价走低。该公司宣布了Tegoprubart在预防移植排斥反应方面的临床进展。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。